Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

August 1, 2024

Conditions
Central Nervous System InfectionsCentral Nervous System ComplicationInfectious Disease of Nervous SystemBlood DiseaseBlood CancerInfection
Trial Locations (22)

75010

Hopital St. Louis, Paris

197022

Raisa Gorbacheva Research Institute for Oncology, Saint Petersburg

Unknown

The Children's Hospital at Westmead, Westmead

Instituto de Cancerologia S.A, Medellín

Carl-Thiem-Klinikum, Cottbus

Jena University Hospital, Jena

University Children's Hospital, Würzburg

Central Hospital of Southern Pest, Budapest

Hadassah University Hospital, Jarusalem

Institute G. Gaslini, Genova

Ospedale San Martino, Genova

Clinica di Oncoematologia Pediatrica, Padua

Universita Cattolica S. Cuore, Rome

University Hospital, Collegium Medicum UMK, Bydgoszcz

University Children's Hospital in Krakow, Krakow

The Medical University of Warsaw, Warsaw

Hospital Santa Creu i Sant Pau, Barcelona

Hospital Univ. 12 de Octubre, Madrid

Niño Jesus Children's Hospital, Madrid

University Hospital La Fe, Valencia

Centre Ntl de greffe de MO de Tunis, Tunis

Hacettepe University Children's Hospital, Antalya

All Listed Sponsors
lead

European Society for Blood and Marrow Transplantation

NETWORK

NCT04737785 - Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter